ALDH2 and breast cancer: We found that patients with breast cancer with ALDH2_rs886205_GG, ALDH2_rs4648328_CC, and ALDH2_rs4767944_TT also showed a significant cognitive decline after chemotherapy (TABLE 3‐5).